<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02296437</url>
  </required_header>
  <id_info>
    <org_study_id>HC14216</org_study_id>
    <nct_id>NCT02296437</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation (tDCS) and Cognitive Task in Depression</brief_title>
  <acronym>tDCS + CT</acronym>
  <official_title>Pilot Study of Transcranial Direct Current Stimulation (tDCS) and Cognitive Task in Depression.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of New South Wales</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of New South Wales</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Among antidepressant treatments, electroconvulsive therapy (ECT) remains the most effective.&#xD;
      However, patient concerns with cognitive side effects have encouraged trials of new,&#xD;
      non-convulsive forms of mild brain stimulation such as transcranial Direct Current&#xD;
      Stimulation (tDCS). Our past and present studies of tDCS suggest that it has antidepressant&#xD;
      effects and is safe, painless and well tolerated. However, not all patients may have an&#xD;
      adequate response, raising the need to find ways of optimising efficacy. This clinical pilot&#xD;
      study will examine the feasibility and safety of combining tDCS with a cognitive training&#xD;
      task which engages the same brain region targeted by tDCS for treatment of depression.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2014</start_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Montgomery and Asberg Depression Rating Scale (MADRS)</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>tDCS + CT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transcranial direct current stimulation combined with cognitive training</intervention_name>
    <arm_group_label>tDCS + CT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Participants are aged 18-65 years.&#xD;
&#xD;
          2. Participant meets criteria for a DSM-V Major Depressive episode. Criteria are as&#xD;
             follows: Five or more symptoms present during the same 2-week period, including either&#xD;
             1 or 2: 1) depressed mood, 2) loss of interest or pleasure, 3) significant weight loss&#xD;
             or gain, 4) insomnia or hypersomnia, 5) psychomotor agitation or retardation, 6)&#xD;
             fatigue or loss of energy, 7) feelings of worthlessness or excessive or inappropriate&#xD;
             guilt, 8) diminished ability to think concentrate or make decisions, and 9) recurrent&#xD;
             thoughts of death, recurrent suicidal ideation, suicide attempt or plan.&#xD;
&#xD;
          3. MADRS score of 20 or more.&#xD;
&#xD;
          4. Right handed&#xD;
&#xD;
          5. A history of non-response to â‰¥ 2 adequate trials of antidepressant medication&#xD;
             treatment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. DSM-V psychotic disorder.&#xD;
&#xD;
          2. Drug or alcohol abuse or dependence (preceding 6 months).&#xD;
&#xD;
          3. Inadequate response to ECT (current episode of depression).&#xD;
&#xD;
          4. Regular benzodiazepine medication&#xD;
&#xD;
          5. Rapid clinical response required, e.g., due to high suicide risk.&#xD;
&#xD;
          6. Clinically defined neurological disorder or insult.&#xD;
&#xD;
          7. Metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash)&#xD;
             at proposed electrode sites.&#xD;
&#xD;
          8. Pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Donel Martin, PhD</last_name>
    <phone>61 2 9382 8353</phone>
    <email>donel.martin@unsw.edu.au</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of New South Wales</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donel Martin, PhD</last_name>
      <phone>61 2 9382 8353</phone>
      <email>donel.martin@unsw.edu.au</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>November 18, 2014</study_first_submitted>
  <study_first_submitted_qc>November 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2014</study_first_posted>
  <last_update_submitted>October 15, 2017</last_update_submitted>
  <last_update_submitted_qc>October 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of New South Wales</investigator_affiliation>
    <investigator_full_name>Melissa Pigot</investigator_full_name>
    <investigator_title>Research assistant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

